Acellular Scaffold for Pancreatic Islet Cell Perfusion
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods for culturing pancreatic islet cells are inefficient due to the lack of efficient perfusion and vascularization, leading to ischemic injury upon transplantation, and existing solutions have not provided conditions for long-term survival and functional glucose-responsive insulin secretion.
Innovation Solution
A devitalized, acellular tissue-derived three-dimensional scaffold with specific dimensions is used to seed pancreatic islet cells, lung cells, or hepatocytes, allowing for the maintenance of organ-specific functions and glucose-responsive insulin secretion, even when cultured on non-homologous matrices.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If pancreatic islet cells are cultured using conventional methods, then cell proliferation can be achieved, but efficient perfusion and vascularization are lacking, leading to ischemic injury upon transplantation
Solution Approach 1:
The scaffold is divided into micro-organs with specific thickness (100-225 micrometers) to ensure adequate perfusion throughout the tissue structure, enabling reliable transplantation survival by segmenting the tissue into manageable units with sufficient vascular access
Solution Approach 2:
A devitalized acellular scaffold derived from micro-organs serves as an intermediary structure that provides the necessary vascularized framework for pancreatic islet cell transplantation, mediating between the cell culture system and the transplantation environment to prevent ischemic injury
2Reliability
If pancreatic islet cells are cultured without proper vascularization, then culture simplicity is maintained, but functional glucose-responsive insulin secretion is compromised over time
Solution Approach 1:
The scaffold provides localized vascularized environments within specific micro-organ regions (100-225 micrometers thick) that create optimal conditions for glucose-responsive insulin secretion, ensuring functional reliability through locally optimized tissue architecture
Solution Approach 2:
The invention transitions from conventional two-dimensional cell culture to three-dimensional micro-organ scaffolds with controlled thickness, adding a dimensional parameter that enables adequate perfusion and maintains long-term functional insulin secretion capabilities
3Strength
If scaffold thickness is increased to provide structural support, then mechanical strength is improved, but diffusion of nutrients and gases to all cells becomes insufficient
Solution Approach 1:
The scaffold thickness is dynamically optimized to a specific range (100-225 micrometers) that balances structural support requirements with the diffusion distance needed for adequate nutrient and gas delivery to all cells within the micro-organ structure
Data Source
AI summary
A composition of matter is provided comprising a devitalized, acellular tissue-derived scaffold seeded with differentiated cells, particularly pancreatic islet cells, wherein the cells can maintain cell-specific function or structure in culture on the scaffold. Methods of generating same and uses thereof are also provided.